Anne Covey, MD
Interventional Radiologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Minimally Invasive Interventional Procedures
- Gastrointestinal Neuroendocrine Tumors
- Liver Cancer
Request an Appointment
About Me
- Attending Radiologist
I am an interventional radiologist who uses CT, MRI, ultrasound, fluoroscopy, and other image guidance to perform minimally invasive procedures. I am passionate about using imaging to avoid the need for an operation. This lets people with cancer have faster recoveries and enhances their quality of life. The procedures I can perform include venous access; drainages of abscesses, fluid collections, and obstructed systems; peripheral angiography; and tumor embolization. I have been practicing radiology at MSK since 2000.
Read more
My primary focus is the minimally invasive treatment of tumors involving the liver and bile ducts. This includes embolotherapy — killing the tumor by blocking the arteries that supply it — and ablation — the application of extreme heat or cold directly into tumors to kill tumor cells — for primary and metastatic liver tumors. I also perform procedures to treat blocked bile ducts in the liver that can cause symptoms of jaundice, infection, and itching. As a member of the Hepatobiliary Disease Management Team, I work with my colleagues from different specialties to provide the best cancer care possible. My research interests include hepatocellular carcinoma and biliary intervention.
I am a trustee of the American Board of Radiology. This position involves creating and delivering the certifying exam for diagnostic radiologists and the new interventional radiology residency.
I also serve on the hepatobiliary panel of the National Comprehensive Cancer Network, which guides patient care. I co-wrote its principles of locoregional therapy for hepatocellular carcinoma.
Working at MSK is extremely rewarding because of the shared mission of all our staff to deliver top-notch care. I enjoy working with people with cancer because we have the same goal: beating cancer. I am proud to work here and am grateful for the opportunity to collaborate with an outstanding team of doctors, nurses, and technologists.
An interventional (IN-ter-VEN-shun-al) radiologist is a doctor with special training in using image-guided procedures to diagnose and treat disease.
My Specialties
- Minimally Invasive Interventional Procedures
- Gastrointestinal Neuroendocrine Tumors
- Liver Cancer
- Liver Metastases (Secondary Liver Cancer)
- Rectal Cancer
Education
- MD, Columbia University College of Physicians and Surgeons
Residencies
- Yale-New Haven Hospital
Awards and Honors
- Castle Connolly: Exceptional Women in Medicine (2024)
- Castle Connolly: America’s Top Doctor (2024)
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Exceptional Women in Medicine Award, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
- Castle Connolly: New York Magazine Top Doctors (2019-2020)
Fellowships
- Yale-New Haven Hospital
Board Certifications
- Diagnostic Radiology
- Interventional Radiology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Covey sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Covey AM, Sofocleous CT. Radiofrequency ablation as a treatment strategy for liver metastases from breast cancer. Sem Interv Radiol 2008;25:406-412
Covey AM. Invited commentary: MDCT/CTA for suspected vascular trauma of the extremities: Evolving role of multiplanar reformations and 3D rendering. Radiographics
Covey AM, Fong Y. Approach to metastatic liver cancer. In: Gastrointestinal Oncology: A Critical MDT Approach. Blackwell Publishing. In press 2008.
Brody LA, Covey AM. Biopsy of the liver and bile duct. In: Surgery of the Liver and Biliary Tract, 4th Edition Lippincott Williams & Wilkins. Editor: Blumgart. W.B. Saunders Co. January 2006 p.354-361
Covey AM, Brown KT. Interventional Oncology In: CANCER: Principles and Practice of Oncology 7th edition. Editors Hellman and Devita. Lippincott Williams & Wilkins. 2004 p.617-636
Covey AM, Getrajdman G. Mediport placement. In: Atlas of Procedures in Gynecologic Oncology. Martin Dunitz 2003 p. 247-252
Visit PubMed for a full listing of Dr. Covey’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Anne Covey discloses the following relationships and financial interests:
-
Amgen
Equity -
Boston Scientific
Professional Services and Activities
-
OncLive
Professional Services and Activities -
PorTal
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].